Literature DB >> 32658532

Tobacco-use behavior and toxicant exposure among current dual users of electronic cigarettes and tobacco cigarettes.

Caroline O Cobb1, Rebecca C Lester1, Alyssa K Rudy1, Cosima Hoetger1, Megan Scott1, Makeda Austin1, Alison Montpetit2, Thokozeni Lipato3, Amanda L Graham4, Andrew J Barnes3, Thomas Eissenberg1.   

Abstract

Electronic cigarette (e-cigarette) use continues to grow with most users reporting concurrent cigarette smoking, but few studies have focused on tobacco use and toxicant exposure among naturalistic dual-using populations. This controlled clinical laboratory study examined how dual versus exclusive use of e-cigarettes and cigarettes and no tobacco/nicotine affected behavioral, physiological, and subjective measures among current dual users. Twenty-two participants identifying as cigarette (≥ 10 cigarettes per day [CPD]) and e-cigarette (≥ 3 days/week) users of "cig-a-like" e-cigarettes completed four 5-day outpatient conditions, which differed by their own brand of products used ad libitum: (a) cigarette and e-cigarette (dual), (b) cigarette-only, (c) e-cigarette-only, and (d) no tobacco/nicotine. Primary outcomes included daily tobacco use, expired air carbon monoxide (CO), and urinary cotinine and NNAL. Linear mixed models with pairwise comparisons (Bonferroni corrected) were performed (p < .05). CPD did not differ significantly between dual and cigarette-only use, but e-cigarette use and liquid consumed increased significantly during e-cigarette-only relative to dual use. Relative to dual use, expired air CO did not differ during cigarette-only and was significantly lower during e-cigarette-only use. Urinary cotinine was significantly lower during e-cigarette-only use relative to dual and cigarette-only use, while urinary NNAL did not differ between the nicotine-containing conditions. In summary, among current dual users, e-cigarettes in combination with cigarettes did not reduce CPD relative to exclusive cigarette use or toxicant exposure relative to exclusive use of either product. However, exclusive e-cigarette use did reduce CO and cotinine, highlighting the benefits of cigarette cessation. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Entities:  

Mesh:

Year:  2020        PMID: 32658532      PMCID: PMC9307076          DOI: 10.1037/pha0000417

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.492


  38 in total

1.  Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Authors:  Sarah E Evans; Melissa Blank; Cynthia Sams; Michael F Weaver; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

2.  Evaluating oral noncombustible potential-reduced exposure products for smokers.

Authors:  Melissa D Blank; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2010-02-16       Impact factor: 4.244

3.  Novel liquid chromatographic-tandem mass spectrometric methods using silica columns and aqueous-organic mobile phases for quantitative analysis of polar ionic analytes in biological fluids.

Authors:  W Naidong; W Shou; Y L Chen; X Jiang
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-04-25

4.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

5.  Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report.

Authors:  Carolina P Ramôa; Marzena M Hiler; Tory R Spindle; Alexa A Lopez; Nareg Karaoghlanian; Thokozeni Lipato; Alison B Breland; Alan Shihadeh; Thomas Eissenberg
Journal:  Tob Control       Date:  2015-08-31       Impact factor: 7.552

Review 6.  Electronic cigarettes: what are they and what do they do?

Authors:  Alison Breland; Eric Soule; Alexa Lopez; Carolina Ramôa; Ahmad El-Hellani; Thomas Eissenberg
Journal:  Ann N Y Acad Sci       Date:  2016-01-15       Impact factor: 5.691

7.  Reasons for current E-cigarette use among U.S. adults.

Authors:  Deesha Patel; Kevin C Davis; Shanna Cox; Brian Bradfield; Brian A King; Paul Shafer; Ralph Caraballo; Rebecca Bunnell
Journal:  Prev Med       Date:  2016-09-07       Impact factor: 4.018

8.  Acute effects of JUUL and IQOS in cigarette smokers.

Authors:  Sarah Maloney; Alisha Eversole; Melanie Crabtree; Eric Soule; Thomas Eissenberg; Alison Breland
Journal:  Tob Control       Date:  2020-02-10       Impact factor: 7.552

9.  Biomarkers of Exposure Among "Dual Users" of Tobacco Cigarettes and Electronic Cigarettes in Canada.

Authors:  Christine D Czoli; Geoffrey T Fong; Maciej L Goniewicz; David Hammond
Journal:  Nicotine Tob Res       Date:  2019-08-19       Impact factor: 4.244

10.  Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and Acrolein.

Authors:  Hayden McRobbie; Anna Phillips; Maciej L Goniewicz; Katie Myers Smith; Oliver Knight-West; Dunja Przulj; Peter Hajek
Journal:  Cancer Prev Res (Phila)       Date:  2015-09
View more
  1 in total

1.  Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers.

Authors:  Gal Cohen; Nicholas I Goldenson; Patrick C Bailey; Stephanie Chan; Saul Shiffman
Journal:  Nicotine Tob Res       Date:  2021-11-05       Impact factor: 4.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.